SUD 0.00% 4.2¢ suda pharmaceuticals ltd

Ann: SUDA Enters Agreement To Develop Cannabinoid Spray, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 23,832 Posts.
    lightbulb Created with Sketch. 725
    @Beale

    The answer is simple, either SUD don’t receive $170K per month from Strides (as I believe), or SC is braindead

    Nowhere in the original announcement does it refer to $170k/month retainer. That is $2Mp.a+ in fees, yet no mention at all in their terms of the agreement ?

    B44B7532-E9B5-4128-A1E3-1B74CA6C83E8.jpeg

    Why would they propose to pay $400k upfront and $600k on milestones around a clinical study, but be happy to pay $680K per quarter in fees to SUD irrespective of performance ?

    It makes no sense and I very much doubt SUD net $170K per month from Strides

    Correct me if I’m wrong, but you are claiming that between Strides and this deal, SUD net $270k per month in fees, or $3.2Mp.a ?

    Come on now ...
    Last edited by vontrader: 06/12/18
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.